HomeXFOR • NASDAQ
add
X4 Pharmaceuticals Inc
Previous close
$3.02
Day range
$2.90 - $3.07
Year range
$2.90 - $33.90
Market cap
16.90M USD
Avg Volume
133.12K
P/E ratio
1.30
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 28.81M | — |
Operating expense | 33.53M | -10.07% |
Net income | 282.00K | 100.54% |
Net profit margin | 0.98 | — |
Earnings per share | 0.04 | 100.51% |
EBITDA | -8.97M | 75.91% |
Effective tax rate | 10.76% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 86.95M | 7.52% |
Total assets | 130.01M | 15.89% |
Total liabilities | 107.07M | -3.67% |
Total equity | 22.94M | — |
Shares outstanding | 5.79M | — |
Price to book | 0.76 | — |
Return on assets | -17.08% | — |
Return on capital | -23.46% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 282.00K | 100.54% |
Cash from operations | -12.37M | 63.19% |
Cash from investing | -3.14M | 41.04% |
Cash from financing | — | — |
Net change in cash | -15.43M | 60.40% |
Free cash flow | -14.73M | 27.92% |
About
Founded
Mar 13, 2019
Headquarters
Website
Employees
143
